Chen Chao

Email 1312526154@qq.com

Personal profile:

     Chen Chao, PhD student, graduated from Hunan Normal University with both undergraduate and master degrees. In September 2019, he entered Nanjing University of Traditional Chinese Medicine to study for a doctorate degree. His tutor is Professor Han Xin, who specializes in the foundation of integrated traditional Chinese and Western medicine.

Presided over 1 graduate research and innovation project in Hunan Province and participated in 3 National Natural Science Foundation of China. The main research interests are the use of multifunctional biomaterials for controlled nucleic acid delivery. As the first author or corresponding author, he has published 6 academic papers in SCI journals such as Small, Signal Transduction and Targeted Therapy, American Journal of Translational Research, Journal of Cancer, Anticancer Drugs, etc. As a co-author, he has published 5 academic papers in SCI journals such as Angewandte Chemie International Edition, ACS Applied Materials & Interfaces. Served as a reviewer for SCI journals such as Signal Transduction and Targeted Therapy.

Representative academic papers:

1. Chen C.#, Ma Y.#, Du S., Wu Y., Shen P., Yan T., Li X., Song Y.*, Zha Z.*, Han X.*. (2021). Controlled CRISPR-Cas9 Ribonucleoprotein Delivery for Sensitized Photothermal Therapy. Small. e2101155. doi: 10.1002/smll.202101155. (Front Cover)

2. Dai J.#, Su Y.#, Zhong S.#, Cong L., Liu B., Yang J., Tao Y., He Z., Chen C.*, Jiang Y.*. (2020). Exosomes : key players in cancer and potential therapeutic strategy. Signal Transduction and Targeted Therapy.  5, 145.

3. Li X.#, Pan Y.#, Chen C., Gao Y., Liu X., Yang K., Luan X., Zhou D., Zeng F., Han X.*, Song Y*. (2021) . Hypoxia-Responsive Gene Editing to Reduce Tumor Thermal Tolerance for Mild-Photothermal Therapy. Angewandte Chemie International Edition. doi: 10.1002/anie.202107036.

4. Qu L.#, Chen C.#, He W., Chen Y., Li Y., Wen Y., Zhou S., Jiang Y., Yang X., Zhang R., Shen L.*. (2019) . Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K/AKT/mTOR pathway. American Journal of Translational Research.  11, 2042-2055.

5. Chen C.#, Lu L., Yan S., Yi H., Yao H., Wu D., He G., Tao X., Deng X.*. (2018). Autophagy and doxorubicin resistance in cancer. Anticancer Drugs.  29, 1-9.